hypoxanthine has been researched along with African Sleeping Sickness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cestari, I; Chen, J; Leija, C; Li, Q; Phillips, MA; Rijo-Ferreira, F; Stuart, K; Tu, BP | 1 |
| Brun, R; Iten, M; Kaminsky, R; Matovu, E | 1 |
| El Malik, KH; El Rayah, IE; Kaminsky, R; Schmid, C | 1 |
3 other study(ies) available for hypoxanthine and African Sleeping Sickness
| Article | Year |
|---|---|
GMP synthase is essential for viability and infectivity of Trypanosoma brucei despite a redundant purine salvage pathway.
Topics: Adenosine; Animals; Binding Sites; Carbon-Nitrogen Ligases; Cell Cycle; Gene Knockout Techniques; Guanine; Guanosine Monophosphate; Humans; Hypoxanthine; Metabolic Networks and Pathways; Mice, Inbred C57BL; Purines; Recombinant Proteins; Trypanosoma brucei brucei; Trypanosomiasis, African | 2015 |
Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
Topics: Animals; Drug Resistance; Eflornithine; Female; Humans; Hypoxanthine; Hypoxanthines; Melarsoprol; Mice; Mice, Inbred ICR; Nifurtimox; Species Specificity; Suramin; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Trypanosomiasis, African; Uganda | 1995 |
Drug resistance in Sudanese Trypanosoma evansi.
Topics: Animals; Camelus; Chromatography, Ion Exchange; Drug Resistance; Female; Hypoxanthine; Inhibitory Concentration 50; Mice; Mice, Inbred ICR; Phenanthridines; Quinolinium Compounds; Scintillation Counting; Sudan; Suramin; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African | 1999 |